Advantages

• Important contribution to an effective management program of diarrhoea control in foals
• Foals from vaccinated mares are spared the growth rate check caused by Rotavirus disease
• Reduction in associated veterinary costs for therapeutic treatment

Clinical Use

Use entire contents immediately upon opening. Administer 1 mL intramuscularly in the 8th, 9th and 10th months of pregnancy using aseptic technique. A yearly booster dose should be given one month prior to foaling for each subsequent pregnancy.

Human Safety

Additional user safety

Take care to avoid accidental self-injection. In the event of self- administration, seek prompt medical attention and take this package leaflet/carton with you. Accidental self-administration may result in local bruising, severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If pain persists for more than 12 hours after medical examination, seek medical advice again.

First Aid Statement

If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126.

Registered label warnings

Withholding Periods

Zero (0) days

ESI

ESI not applicable

Side Effects

Allergic reactions such as anaphylaxis occur rarely and may require parenteral treatment with an antihistamine, a corticosteroid or adrenalin as appropriate.

Precautions

For use in pregnant mares only.

Foals born from vaccinated mares may still show signs of diarrhoea. Thorough diagnosis of the infectious agents, including rotavirus, is recommended to assist in the control of infectious diarrhoea.